Andarix Pharmaceuticals Inc logo

Andarix Pharmaceuticals Inc

Andarix Pharmaceuticals is developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond. Tozaride, our lead product entering Phase 2 clinical trials, targets specific cancers at the molecular level, and its companion diagnostic identifies the patients with the corresponding molecular signature who are the best candidates for therapy

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.andarix.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Somerville
Massachusetts
United States
Email
Contact Number
+1 617-957-9858

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]